Background: Plasma clearance of iohexol is a reliable method to assess the glomerular filtration rate (GFR). The relationship between aging and GFR in horses is unclear.
of glomerular sclerosis and loss of residual renal function. 2 In neonatal Pony foals, GFR did not seem to change significantly over the first 10 days from birth, and was similar to the GFR of adult horses. 5 Plasma clearance (Clp) of iohexol (IOX) is a technically simple and accurate method for GFR evaluation in clinically healthy horses, 6, 7 foals, 8 and donkeys. 7 To the authors' knowledge, there are currently no data concerning possible variations of GFR among clinically healthy horses of various ages. The aim of the present study was to investigate GFR in healthy young and adult horses, using the Clp of IOX.
| MATERIALS AND METHODS

| Animals
A total of 21 stallion horses were enrolled in this prospective study.
All the subjects were submitted to clinical examination, CBC, total proteins, serum creatinine, and urea concentrations. The horses were divided in 3 groups based on age 9, 10 and serum creatinine concentration. For serum creatinine, a cutoff value of 1.5 mg/dL was considered. We decided to use the cutoff of 1.5 mg/dL because it represented the upper third of the reference range for horses in our laboratory (0.9-1.7 mg/dL). Aged horses were divided into 2 groups according to a serum creatinine less or greater than 1.5 mg/dL. In particular, Group A was composed by 8 young horses (≤15 years old) 9 with serum creatinine concentration <1.5 mg/dL, Group B was composed by 7 aged horses (≥20 years old) 10 with serum creatinine concentration <1.5 mg/dL, and Group C was composed by 6 aged horses (≥20 years old) 10 with serum creatinine ≥1.5 mg/dL. Glomerular filtration rate was assessed by plasma IOX clearance. Horses were provided with hay and water ad libitum during all the study period.
During the entire time of the procedure, horses were checked for vital parameters (body temperature, respiratory rate, heart rate, and mental status), and possible anaphylactic reactions every 30 minutes.
Approval to conduct this study was obtained by the Ethic Committee on Animal Experimentation of the University of Pisa (D.L. 26/2014).
An owner written consent has been obtained.
| Plasma IOX clearance
A sterile 14-gauge IV catheter (Surflash, Terumo Italia S.r.l., Rome, Italy) was aseptically placed in both left and right jugular veins and locked with a sterile cap. The right IV catheter was used only for IOX administration. The left catheter was used for blood sampling, in order to minimize venipuncture. Before and after each blood sampling, the catheter was flushed with 2.5 mL of sterile 0.9% saline solution. The first 5 mL of blood collected were discarded, then 2.5 mL of blood was collected in lithium heparin tubes.
A commercially available IOX formulation (Omnipaque 350, Nycomed Imaging AS, Oslo, Norway) was administered as an IV bolus (within 1 minute) at a dose of 75.5 mg/kg, through the right jugular catheter. To determine the exact dose administered, the syringe and the needle used for IOX infusion were weighed before and after injection. Blood samples were collected through the left jugular catheter before IOX bolus (T0), and at 5, 30, and 90 minutes from completion of IOX inoculation. Blood samples were centrifuged at 3000 rpm for 10 minutes. Plasma was stored in aliquots at −20 C until highperformance liquid chromatography analysis. 7 In Group A, urea, creatine, and GFR were 11 mg/dL (10-13 mg/ dL), 1 mg/dL (0.9-1.2 mg/dL), and 2.60 mL/min/kg (2.00-2.80 mL/ min/kg) (median, minimum, and maximum), respectively. In Group B the urea, creatine, and GFR were 20 mg/dL (12-32 mg/dL), 1.3 mg/dL (1.0-1.4 mg/dL), and 2.10 mL/min/kg (1.90-2.50 mL/min/kg), respectively. In Group C, urea, creatinen and GFR were 21 mg/dL (15-40 mg/dL), 1.5 mg/dL (1.5-1.7 mg/dL), and 1.45 mL/min/kg (1.05-2.10 mL/min/kg), respectively.
| Pharmacokinetic and statistical analysis
The Kruskal-Wallis test showed statistically differences for urea (P = .0001), creatinine (P = .0001), and GFR (P = .0003) among groups.
Dunn's post hoc test showed a significance difference between Group A versus C for urea, between Group A versus B and Group A versus C for creatinine, and between Group A versus C for GFR ( Figure 1 ).
| DISCUSSION
Plasma clearance of IOX showed a clinically suitable and safe procedure for GFR determination in both young and aged horses. During the entire time of the procedure, horses were checked for vital parameters (body temperature, respiratory rate, heart rate, and mental status) and possible anaphylactic reactions. None of the horses showed clinically relevant adverse reactions to the inoculation of IOX. Glomerular filtration rate was not significantly different between Groups A and B. In addition, the GFR values of both young horses (2.50 mL/ min/kg) and aged horses with serum creatinine <1.5 mg/dL (2.20 mL/ min/kg) were close to previously findings for plasma IOX clearance (2.15 mL/min/kg in foals, and 2.38 mL/min/kg and 2.36 mL/min/kg in adult horses, respectively). [6] [7] [8] In our study, aged horses with serum creatinine ≥1.5 mg/dL (Group C) showed a significantly lower GFR (1.50 mL/min/kg) than young horses (Group A).
Our initial explanation for the reduction of GFR in aged horses was secondary to the physiological aging process of kidneys. This finding seems to be in agreement with current data in both human and veterinary medicine, in which the aging kidney is characterized by structural and physiological changes that are responsible for a reduction in GFR. 1, 2, 13 In humans, the kidney aging process starts around 50 years of age, and it is characterized by both macroscopic and microscopic structural changes. Macroscopic alterations are represented by an increase in medullary volume, number of renal cysts, surface roughness, and a reduction in cortical volume. Microscopic alterations are characterized by a reduction in nephron number, and increased glomerular and interstitial fibrosis. 13 People <40 years old are expected to have <10% of globally sclerotic glomeruli, whereas this percentage increases significantly with aging, particularly after 50 years of age. 14 Aging-related glomerulosclerosis has a multifactorial pathogenesis. 15 Similar findings have been reported in veterinary species, where a review of histopathology kidney changes in aged dogs, showed an increased frequency in glomerulosclerosis and obsolescent glomeruli. 2 Aged dogs are more commonly characterized by increased thickness of the glomerular basement membrane. 16 In dogs, tubulointerstitial lesions seem to be a less frequent consequence of renal aging. Occasionally, signs of interstitial fibrosis and tubular atrophy are reported. 2 Tubulointerstitial lesions seem to be more frequent in aged humans, where they are generally associated with glomerulosclerosis. 17 Beside structural changes in kidney architecture, aging is also responsible for a reduction in overall renal function.
In human beings, GFR declines after 30 years of age by approximately 1 mL per year. 18 However, the exact influence of age on renal function and GFR in veterinary medicine is still debated.
For dogs, there are contrasting results. In one study, 19 2-monthold puppies had a significantly higher mean GFR than mature dogs.
On the other hand, Bexfield and Colleagues 20 showed that GFR was affected by age only in the group of dogs with a BW of between 1.8 and 12.4 kg. In this group of dogs, age alone was responsible for 12.5% of GFR variation. In dogs with BW > 12.4 kg, no effects of age on GFR were reported. Bexfield and Colleagues 20 hypothesized that the discrepancy between what is found in human medicine and their results might be affected by the lower life span of dogs, compared to humans. 20 In aged dogs, the reduction in GFR might not be as evident as in humans, despite the presence of similar histopathological lesions. 20 Companion horses have a higher average life span than dogs, which may predispose horses to develop a level of glomerulosclerosis that is more similar to geriatric human patients. 21 Therefore, it is possible that the discrepancy in GFR between young and aged horses may be secondary to a physiological increase in glomerulosclerosis, because of the aging process. Unfortunately, no histopathological exam was performed at the time GFR was evaluated, so we are unable to confirm our hypothesis.
On the other hand, it is possible that the significantly lower GFR of old horses of Group C, compared to Group A, was determined by the presence in Group C of horses with early stages of CKD. This hypothesis may be supported by the lack of significant difference in GFR between young horses and aged horses with serum creatinine <1.5 mg/dL of Group B. Horses of Group C had a serum creatinine ≥1.5 mg/dL, which was at the upper third of the reference range of our laboratory (0.9-1.7 mg/dL). Therefore, it is possible that these horses had early stage CKD, despite no clinical signs and normal F I G U R E 1 Dot plots displaying the actual values of glomerular filtration rate (GFR) for horses in Groups A (young horses with creatinine <1.5 mg/dL), B (aged horses with creatinine <1.5 mg/dL), and C (aged horses with creatinine ≥1.5 mg/dL). The different lowercase letters above the dot plots denote a significant difference (a 6 ¼ ab 6 ¼ b: P < .05). The horizontal lines represent the median, minimum, and maximum values creatinine values. The reference range for serum creatinine of our laboratory may be too wide, thus classifying horses with low grade CKD as normal. A reduction in GFR despite normal serum creatinine is a typical finding of early stage CKD. Glomerular filtration rate is, in fact, considered the best indicator of overall renal function, with a higher sensitivity than serum creatinine in detecting small changes in renal function. As the kidney has a high reserve capacity, increase in serum creatinine is not evident until GFR reduces over 75%. 22 The present study has some limitations. First, GFR evaluation was not accompanied by kidney biopsy. As a consequence, we had no opportunity to evaluate the degree of glomerulosclerosis, or other pathological findings, in the Group C kidneys. Second, a limited number of horses were included in the study. Another limitation was the lack of urinalysis for all the horses of the study. Urinalysis would have been a useful tool to rule out early signs of CKD (such as reduction in urine specific gravity [USG]), particularly for horses of Group C. However, as all horses of Group C were stallions, which did not urinate spontaneously during the procedure, we opted not to catheterize them. Urinary catheterization in stallions is usually performed under sedation, and vasoactive drugs might affect glomerular hemodynamics, and GFR. To support our choice, the absence of clinical signs of renal failure, the normal hydration status, and serum creatinine within the normal reference range made prerenal azotemia unlikely.
Another limitation of the present study was represented by the lack of a group of young horses with serum creatinine ≥1.5 mg/dL. As a consequence, the role of a serum creatinine ≥1.5 mg/dL in affecting GFR could not be investigated. The relatively low number of patients, together with a significant variability in terms of breed and BW, might affect the homogeneity of the sample. For this reason, a study with a larger number of patients, and with horses of various ages, breeds, and BWs would be recommended.
In conclusion, GFR was significantly reduced in aged horses with serum creatinine ≥1.5 mg/dL compared to aged horses with creatinine <1.5 mg/dL and to young horses. Although serum creatinine, serum urea, and USG remain the most commonly used parameters for the diagnosis of CKD in equine medicine, GFR evaluation should be encouraged, particularly in aged horses.
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